Paradigm BiopharmaceuticalsPAR 
$0.16-2.08%24h
-2.08%24h
Global rank24636
Market cap$46.20M
Change 7d0.00%
YTD Performance-46.59%
SP500 benchmarkUnderperform
P/E-0.89
P/S1455.83
Revenue$31.73K
Earnings-$35.23M
Dividend yield-
Main Sector
Healthcare
Paradigm Biopharmaceuticals PAR Operating Margins
Operating Margin in 2022: -1283.97%
According to Paradigm Biopharmaceuticals latest financial reports the company has an operating margin of -1283.97%, an increase of 111.96% to 2022. At the end of 2022 company had an operating margin of -605.76%.
Paradigm Biopharmaceuticals Operating Margin from 2021 to 2024
-
Value:-
PAR Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -1283.97% | 111.96% |
| 2022 | -605.76% | -71.31% |
| 2021 | -2111.47% | - |
View the highest operating margin companies 
